IMAX vs META

IMAX presents a dichotomy between strong operational growth and poor deterministic value metrics. While the Piotroski F-Score of 4/9 indicates stable financial health and the company shows impressive revenue growth (35.10%) and consistent earnings beats, the stock trades at a massive premium to its Graham Number ($9.42) and Intrinsic Value ($4.41). The bullish analyst sentiment and attractive PEG ratio (0.93) are heavily offset by aggressive insider selling and a bearish technical trend.

META exhibits exceptional fundamental health with a Piotroski F-Score of 8/9, indicating strong financial strength across most key metrics. While the current price of $671.34 trades at a significant premium to the Graham Number ($213.08) and the growth-based Intrinsic Value ($541.67), this is justified by a highly attractive Forward P/E of 18.62 and a PEG ratio of 1.10. The company maintains elite profitability margins (82% Gross, 41.3% Operating) and robust revenue growth of 23.8% YoY. Despite bearish insider sentiment and short-term technical weakness, the underlying operational performance and analyst consensus suggest significant upside toward the $855 target.